Last reviewed · How we verify
NCT04571723
Health Mindset as a Driver of Efficacy of a Diabetes Prevention Program in the Blackfeet Community
NA trial testing Diabetes Prevention Program in Diabetes Mellitus, Type 2 in 24 participants. Completed in 30 March 2022.
30 January 2022
Quick facts
| Lead sponsor | Montana State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 24 |
| Start date | 1 October 2021 |
| Primary completion | 30 January 2022 |
| Estimated completion | 30 March 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Diabetes Prevention Program
- Health Mindset modified diabetes prevention program
Conditions studied
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Sponsor
Montana State University
Who can join
Adults 18 to 50, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of this project is to understand whether the established Diabetes prevention program works to reduce diabetes risk by shifting mindsets about health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04571723
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Diabetes Prevention Program
Trials testing the same drug.
- NCT06372860 — DPP Feasibility Study of Breastfeeding - eMOMS 2.0 · NA · completed
- NCT06965075 — The SCULPT-Job Cohort Study · NA · completed
- NCT05301413 — Social Determinants and a Diabetes Prevention Program Tailored for African Americans · Phase 2 · recruiting
- NCT04709549 — ObeSity and Jobs in SoCioeconomically Disadvantaged CommUnities: A Randomized CLinical Precision Public HealTh Intervent · NA · completed
- NCT04927871 — Hybridized Three Steps Intervention to Prevent Diabetes in Venezuela · NA · completed
Other recruiting trials for Diabetes Mellitus, Type 2
Currently open trials in the same condition.
- NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
- NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
- NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
- NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
Other Montana State University trials
Trials by the same sponsor.
- NCT07460973 — Nen ŨnkUmbi/EdaHiYedo Plus (We Are Here Now Plus): a Multi-level Intervention to Reduce Health Disparities Among America · NA · not yet recruiting
- NCT06938386 — Pilot Haskap Metabolite Timing Project · NA · active not recruiting
- NCT06878885 — Trauma and Cardiometabolic Health in an American Indian Community · NA · recruiting
- NCT05734014 — Strengthening Healthy Relationships Among Apsaalooke Youth · NA · completed
- NCT06298149 — Reach Through Equitable Implementation of Turtle Island Tales · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04571723 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Montana State University
- Last refreshed: 5 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04571723.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing